HT-100
HALO-DMD-01
Phase 2 small_molecule terminated
Quick answer
HT-100 for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Processa Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Processa Pharmaceuticals
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated